Evidence map›Paper›PMID 41193685›Full record

ReviewPlanta2025

Therapeutic potential of medicinal plant sprouts: emerging opportunities and challenges in phytochemistry.

Dominika Melegova, Andrea Babelova, Michal Selc

Abstract readReview
In one paragraph

Review in Planta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Comparative assessment ofFrontiers in nutrition · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Dominika MelegovaDepartment of Nanobiology, Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
Andrea BabelovaDepartment of Nanobiology, Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
Michal SelcDepartment of Nanobiology, Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia. michal.selc@savba.sk.ORCID http://orcid.org/0000-0002-7330-6655

Funding

Agentúra na Podporu Výskumu a Vývoja APVV-16-0579Vedecká Grantová Agentúra MŠVVaŠ SR a SAV 2/0116/22
6 · The paper itself

Abstract

MAIN

conclusionGermination is a developmental stage in which plants accumulate higher levels of bioactive metabolites. However, this potential remains largely unexplored in medicinal herbs and therapeutic applications. Sprouting represents a brief yet metabolically dynamic phase in plant development, during which dormant seeds initiate enzymatic activation and begin synthesizing a range of bioactive compounds. Compared to dry seeds or mature plants, sprouts often contain higher levels of phenolics, flavonoids, vitamins, and other secondary metabolites, enhancing their nutritional and pharmacological value. While edible sprouts from food crops have been extensively studied, sprouts derived from medicinal plants remain largely overlooked. This is surprising given their natural richness in pharmacologically relevant phytochemicals. This perspective draws primarily on original experimental studies that investigated phytochemical and physiological changes during sprouting of medicinal plants. These studies were identified through searches in scientific databases using keywords related to medicinal plants, sprouts, and bioactive compounds. We summarize existing studies on species such as Trigonella foenum-graecum, Nigella sativa, Silybum marianum, Arctium lappa, Trifolium pratense, and Glycyrrhiza uralensis, and identify other promising candidates with high germination potential but uncharacterized phytochemical profiles at the sprout stage. Environmental variables, such as light quality, seed priming, or nutrient supplementation, can further modulate phytochemical composition during germination. We also discuss practical limitations, including low biomass yield, microbial safety concerns, and lack of standardized protocols. Overall, sprouts offer a responsive, scalable, and experimentally tractable model for exploring and optimizing phytochemical expression in medicinal plants. We propose that this early developmental window offers overlooked opportunities for phytopharmacology, functional foods, and natural product discovery.

Indexed as

PhytochemicalsPlants, MedicinalSeedlingsGerminationHumansPhytotherapySeedsPhytochemicalsGerminationPhytochemicalsSecondary metabolitesSeedSproutsTherapeutic potential

Identifiers

PMID41193685
PMCPMC12589205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.